The DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
Open accessAbstract
The metalloproteinase (MP) family of zinc-dependent proteases, including matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs), and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs) plays a crucial role in the extracellular matrix (ECM) remodeling and degradation activities. A wide range of substrates of the MP family includes ECM components, chemokines, cell receptors, and growth factors. Metalloproteinases activities are tightly regulated by proteolytic activation and inhibition via their natural inhibitors, tissue inhibitors of metalloproteinases (TIMPs), and the imbalance of the activation and inhibition is responsible in progression or inhibition of several diseases, e.g., cancer, neurological disorders, and cardiovascular diseases. We provide an overview of the structure, function, and the multifaceted role of MMPs, ADAMs, and TIMPs in several diseases via their cellular functions such as proteolysis of other cell signaling factors, degradation and remodeling of the ECM, and other essential protease-independent interactions in the ECM. The significance of MP inhibitors targeting specific MMP or ADAMs with high selectivity is also discussed. Recent advances and techniques used in developing novel MP inhibitors and MP responsive drug delivery tools are also reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–246 of 246
Evaluation of Periostat for patient management.
Caton, J. G. (1999) · PubMed · Cited by 42
Shiryaev, S. A., Remacle, A. G., Golubkov, V. S., Ingvarsen, S., Porse, A., Behrendt, N., Cieplak, P., & Strongin, A. Y. (2013) · Oncogenesis · doi:10.1038/oncsis.2013.44 · Cited by 42
Simple Pseudo-dipeptides with a P2′ Glutamate
Devel, L., Beau, F., Amoura, M., Vera, L., Lajeunesse, E. C., Garcia, S., Czarny, B., Stura, E. A., & Dive, V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.380782 · Cited by 42
Williamson, R. A., Hutton, M., Vogt, G., Rapti, M., Knäuper, V., Carr, M. D., & Murphy, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101843200 · Cited by 41
Cuvelliez, M., Vandewalle, V., Brunin, M., Beseme, O., Hulot, A., de Groote, P., Amouyel, P., Bauters, C., Marot, G., & Pinet, F. (2019) · Scientific Reports · doi:10.1038/s41598-019-55727-1 · Cited by 41
Musardo, S., & Marcello, E. E. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.06.018 · Cited by 40
Cui, Q., Wang, B., Li, K., Sun, H., Tao, H., Zhang, Y., & Kang, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.9092 · Cited by 40
Inhibitors of gelatinase B/matrix metalloproteinase-9 activity
Hu, J., den Steen, P. E. V., Houde, M., et al. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.10.030 · Cited by 39
Mora‐Gutiérrez, J. M., Rodríguez, J. A., Fernández‐Seara, M. A., Orbe, J., Escalada, J., Soler, M. J., Roblero, M. F. S., Riera, M., Páramo, J. A., & Garcı́a-Fernández, N. (2020) · Scientific Reports · doi:10.1038/s41598-019-56856-3 · Cited by 39
Qi, J. H., Ebrahem, Q., Ali, M., Cutler, A., Bell, B. A., Prayson, N. F., Sears, J. E., Knäuper, V., Murphy, G., & Anand‐Apte, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055667 · Cited by 35
Kocer, S. S., Walker, S. G., Zerler, B. R., Golub, L. M., & Simon, S. R. (2005) · Infection and Immunity · doi:10.1128/iai.73.11.7548-7557.2005 · Cited by 35
Nath, N., Prasad, H. K., & Kumar, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27120 · Cited by 35
Ren, J., Huang, T., Zhang, Q., Zhang, H., Guo, X., Fan, H., Li, R., & Liu, L. (2018) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2018.08.008 · Cited by 34
Jang, B., Jung, H., Choi, S., Lee, Y. H., Lee, S., & Oh, E. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.793752 · Cited by 32
Secret, E., Crannell, K. E., Kelly, S. J., Villancio‐Wolter, M. K., & Andrew, J. S. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00443h · Cited by 31
Deryugina, E. I., Ratnikov, B. I., & Strongin, A. Y. (2003) · International Journal of Cancer · doi:10.1002/ijc.10977 · Cited by 30
Protein kinase D3 modulates MMP1 and MMP13 expression in human chondrocytes
Baker, J. R., Falconer, A. M. D., Wilkinson, D., Europe‐Finner, G. N., Litherland, G. J., & Rowan, A. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195864 · Cited by 30
Identification of highly selective MMP‐14 inhibitory Fabs by deep sequencing
Lopez, T., Nam, D. H., Kaihara, E., Mustafa, Z., & Ge, X. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26248 · Cited by 29
Matrix Metalloproteinase-13 in Atherosclerotic Plaque Is Increased by Influenza A Virus Infection
Lee, H. S., Noh, J. Y., Shin, O. S., Song, J. Y., Cheong, H. J., & Kim, W. J. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz580 · Cited by 29
Elezkurtaj, S., Kopitz, C., Baker, A. H., Pérez‐Canto, A., Arlt, M., Khokha, R., Gänsbacher, B., Anton, M., Brand, K., & Krüger, A. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.637 · Cited by 28
Ferretti, G., Bacchetti, T., Banach, M., Simental‐Mendía, L. E., & Sahebkar, A. (2017) · Angiology · doi:10.1177/0003319716688301 · Cited by 28
Hussain, A. A., Lee, Y., & Marshall, J. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.100775 · Cited by 28
Tissue inhibitor metalloproteinase-1 and clinical outcomes after acute ischemic stroke
Zhong, C., Wang, G., Xu, T., Zhu, Z., Guo, D., Zheng, X., Wang, A., Bu, X., Peng, H. Y., Chen, J., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008389 · Cited by 28
Wang, Q., Liu, X.-S., Zhang, J., Lü, L., Feng, M., & Wang, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10740 · Cited by 28
Brilha, S., Sathyamoorthy, T., Stuttaford, L. H., Walker, N. F., Wilkinson, R. J., Singh, S., Moores, R., Elkington, P. T., & Friedland, J. S. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0162oc · Cited by 27
Development of Capsular Fibrosis Beneath the Liver Surface in Humans and Mice
Balog, S., Li, Y., Ogawa, T., Miki, T., Saito, T., French, S. W., & Asahina, K. (2019) · Hepatology · doi:10.1002/hep.30809 · Cited by 27
Zhou, H., & Zhu, X. (2018) · Cancer Management and Research · doi:10.2147/cmar.s177551 · Cited by 24
MMP-2 salivary activity in type 2 diabetes mellitus patients
Arreguín-Cano, J. A., Ayerdi-Nájera, B., Tacuba-Saavedra, A., Navarro‐Tito, N., Dávalos-Martínez, A., Emigdio-Vargas, A., Barrera-Rodríguez, E., Blanco-García, N., Gutiérrez‐Venegas, G., Ventura-Molina, E., et al. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0510-2 · Cited by 24
Matrix metalloproteinase activity in the lung is increased in Hermansky-Pudlak syndrome
Summer, R. S., Krishna, R., Schriner, D., Cuevas-Mora, K., Sales, D., Para, R., Roman, J., Nieweld, C., Gochuico, B. R., & Romero, F. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1143-0 · Cited by 23
Metalloproteinases and neurodegenerative diseases: pathophysiological and therapeutic perspectives
Rosenberg, G. A. (2015) · Metalloproteinases In Medicine · doi:10.2147/mnm.s68849 · Cited by 22
Bhowmick, M., Stawikowska, R., Tokmina‐Roszyk, D., & Fields, G. (2015) · ChemBioChem · doi:10.1002/cbic.201402716 · Cited by 21
Roeb, E. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i8.1096 · Cited by 21
Brzdąk, P., Nowak, D., Wiera, G., & Mozrzymas, J. W. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00178 · Cited by 21
Serum Matrix Metalloproteinase-9 Is Associated With Depression After Acute Ischemic Stroke
Che, B., Zhong, C., Ge, J., Li, R., Zhu, Z., Bu, X., Xu, T., Ju, Z., Liu, J., Zhang, J., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0376 · Cited by 21
Zhou, Y., Lu, Z., Guo, Y.-J., & Mei, Y.-W. (2010) · Neurological Research · doi:10.1179/016164110x12644252260556 · Cited by 20
Shargh, V. H., Hondermarck, H., & Liang, M. (2017) · Nanomedicine · doi:10.2217/nnm-2016-0419 · Cited by 20
Iannetta, M., Zingaropoli, M. A., Latronico, T., Pati, I., Pontecorvo, S., Prezioso, C., Pietropaolo, V., Cortese, A., Frontoni, M., D’Agostino, C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36535-5 · Cited by 19
Effect of MMP-9 gene knockout on retinal vascular form and function
George, A. K., Homme, R. P., Majumder, A., Tyagi, S. C., & Singh, M. (2019) · Physiological Genomics · doi:10.1152/physiolgenomics.00041.2019 · Cited by 19
Nareznoi, D., Konikov-Rozenman, J., Petukhov, D., Breuer, R., & Wallach‐Dayan, S. B. (2020) · Cells · doi:10.3390/cells9020411 · Cited by 19
Zhang, W., Li, Y., Yang, L., Zhou, B., Chen, K., Meng, W., Liu, Y., Hu, J., Sun, X., & Zhou, Z. (2012) · Clinical and Experimental Medicine · doi:10.1007/s10238-012-0212-7 · Cited by 14
Moreno‐Ajona, D., Irimia, P., Rodríguez, J. A., García‐Velloso, M. J., López–Fidalgo, J., Fernandez‐Alonso, L., Grochowitz, L., Muñóz, R., Domínguez, P. D., Gállego-Culleré, J., et al. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01387-3 · Cited by 14
Naqvi, M. A., Li, H., Gao, W., Naqvi, S. Z., Jamil, T., Aimulajiang, K., Xu, L., Song, X., Li, X., & Yan, R. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-04025-1 · Cited by 14
Latronico, T., & Liuzzi, G. M. (2017) · Metalloproteinases In Medicine · doi:10.2147/mnm.s88655 · Cited by 13
A bi-specific inhibitor targeting IL-17A and MMP-9 reduces invasion and motility in MDA-MB-231 cells
Koslawsky, D., Zaretsky, M., Alcalay, R., Mazor, O., Aharoni, A., & Papo, N. (2018) · Oncotarget · doi:10.18632/oncotarget.25526 · Cited by 9
Yıldırım, Z. N. Y., Yılmaz, A., Pehlivanoğlu, C., Gedikbaşı, A., Yıldız, M., Dırıcan, A., Bundak, R., Darendelıler, F., Emre, S., & Nayır, A. (2019) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2018.2018.0221 · Cited by 9
Tissue Inhibitors of Metalloproteinases ( TIMPs ): Inhibition of Zn‐Dependent Metallopeptidases
Batra, J., & Radisky, E. S. (2014) · Wiley eBooks · doi:10.1002/9781119951438.eibc2168 · Cited by 8
Cited by
Cox, T. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00329-7 · Cited by 976
Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression
Niland, S., Riscanevo, A. X., & Eble, J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010146 · Cited by 503
Jiang, H., & Li, H. (2021) · BMC Cancer · doi:10.1186/s12885-021-07860-2 · Cited by 261
Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Alkhalifa, A. E., Al-Ghraiybah, N. F., Odum, J., Shunnarah, J. G., Austin, N., & Kaddoumi, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216288 · Cited by 212
Liver cirrhosis: An overview of experimental models in rodents
Faccioli, L. A. P., Dias, M. L., Paranhos, B. A., & dos Santos Goldenberg, R. C. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120615 · Cited by 47
Metadata
- Authors
- Raeeszadeh-Sarmazdeh, M., Do, L., & Hritz, B.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-05-25
- Volume
- 9
- Issue
- 5
- Pages
- 1313
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3026399735
- Cited by
- 324
- References
- 246
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.